COMMUNIQUÉS West-GlobeNewswire

Novo Nordisk A/S - Share repurchase programme

09/04/2018 - 13:57

Bagsværd, Denmark, 9 April 2018 - On 5 February 2018, Novo Nordisk initiated a share repurchase programme in accordance with Article 5 of Regulation No. 596/2014 of the European Parliament and Council of 16 April 2014 ( [...]

Share buy-back week 14/2018

09/04/2018 - 13:32

Announcement 9 April 2018 Coloplast – transactions in connection with share buy-back programme As mentioned in Announcement No. 3/2018 Coloplast has initiated the first part of the share buy-back programme totalling up [...]

Conatus Pharmaceuticals Announces Upcoming Oral Presentation at EASL Annual Meeting

09/04/2018 - 13:30

Pan-caspase Inhibitor IDN-7314 Reduces Inflammation and Liver Injury in Mouse Model of PSC SAN DIEGO, April 09, 2018 (GLOBE NEWSWIRE) -- Conatus Pharmaceuticals Inc. (NASDAQ: CNAT ), a biotechnology company focused on [...]

Kura Oncology Announces Upcoming Presentations at AACR Annual Meeting 2018

09/04/2018 - 13:30

SAN DIEGO, April 09, 2018 (GLOBE NEWSWIRE) -- Kura Oncology, Inc. (Nasdaq: KURA ), a clinical-stage biopharmaceutical company focused on the development of precision medicines for oncology, today announced that three [...]

The Joint Corp. Acquires Clinic in San Diego

09/04/2018 - 13:05

– Initiates Growth Acceleration Plan with Clinic Buyback – – Expands Regional Cluster and Leverages Existing Infrastructure – SCOTTSDALE, Ariz., April 09, 2018 (GLOBE NEWSWIRE) -- The Joint Corp. (NASDAQ: JYNT ), a [...]

Cannabis Wheaton Announces Acquisition of Robinson's Cannabis

09/04/2018 - 13:00

VANCOUVER, British Columbia, April 09, 2018 (GLOBE NEWSWIRE) -- Cannabis Wheaton Income Corp. (TSX.V:CBW) (the " Company ") announces that it has entered into a share purchase agreement (the " Share Purchase Agreement [...]

Rhizen Pharmaceuticals S.A. receives FDA orphan-drug designation for Tenalisib (RP6530) for treatment of cutaneous T-cell lymphoma (CTCL)

09/04/2018 - 13:00

La Chaux-de-Fonds, Switzerland, April 09, 2018 (GLOBE NEWSWIRE) -- Rhizen Pharmaceuticals S.A., today announced that the U.S. Food and Drug Administration (FDA) has granted orphan-drug designation for the active moiety [...]

MPX Adds a Fourth Dispensary in Phoenix and Triples Capacity for MPX Concentrate Production in Arizona

09/04/2018 - 13:00

TORONTO, April 09, 2018 (GLOBE NEWSWIRE) -- MPX Bioceutical Corporation (“ MPX ” or the “ Company ”) (CSE:MPX) (OTC:MPXEF) is pleased to announce that the official opening of the its newest “Health for Life” medical [...]

Clinical Laserthermia Systems Introduces MRI-Guided Laser Ablation System for Minimally-Invasive Treatment of Soft Tissue

09/04/2018 - 13:00

FRAMINGHAM, Mass., April 09, 2018 (GLOBE NEWSWIRE) -- Clinical Laserthermia Systems Americas, Inc . (CLS) a subsidiary of CLS AB in Lund, Sweden, today announced the availability of its TRANBERG® Thermal Therapy System [...]

G1 Therapeutics to Present Preclinical Data on CDK4/6 Inhibitors Trilaciclib and G1T38 at the 2018 American Association for Cancer Research (AACR) Annual Meeting

09/04/2018 - 13:00

RESEARCH TRIANGLE PARK, N.C., April 09, 2018 (GLOBE NEWSWIRE) -- G1 Therapeutics, Inc. (Nasdaq: GTHX ), a clinical-stage oncology company, today announced that preclinical data on both of the company’s CDK4/6 inhibitors [...]

RedHill Biopharma Provides Semi-Annual Business Update

09/04/2018 - 13:00

TEL-AVIV, Israel and RALEIGH, N.C., April 09, 2018 (GLOBE NEWSWIRE) -- RedHill Biopharma Ltd. (NASDAQ: RDHL ) (Tel-Aviv Stock Exchange:RDHL) (“RedHill” or the “Company”), a specialty biopharmaceutical company primarily [...]

Tyme Provides Clinical and Corporate Update for Fiscal Year End 2018

09/04/2018 - 13:00

NEW YORK, April 09, 2018 (GLOBE NEWSWIRE) -- Tyme Technologies, Inc. (NASDAQ: TYME ), a clinical-stage oncology company developing metabolically-based cancer therapeutics, today announced a clinical and corporate update [...]

BioVie Inc. (OTCQB:BIVI) Attains Milestone

09/04/2018 - 13:00

Company Reaches 50% Patient Enrollment in Phase 2a Clinical Trial of BIV201 for Refractory Ascites BEVERLY, Mass., April 09, 2018 (GLOBE NEWSWIRE) -- BioVie Inc. (OTCQB:BIVI), a clinical-stage company focused on the [...]

Auris Medical Announces Early Repayment of Part of its Loan Facility

09/04/2018 - 12:45

Zug, Switzerland, April 9, 2018 - Auris Medical Holding AG (NASDAQ: EARS), a clinical-stage company dedicated to developing therapeutics that address important unmet medical needs in neurotology, today announced the [...]

PotNetwork Holding, Inc.'s Diamond CBD, Inc. to be featured at 2018 Telecom Review Summit held in Beirut, Lebanon.

09/04/2018 - 12:30

Exponential, Inc. founder and CEO Dom Einhorn to present keynote panel, “The New Start-Up Ecosystem”. FT LAUDERDALE, Fla., April 09, 2018 (GLOBE NEWSWIRE) -- via OTC PR WIRE--PotNetwork Holding, Inc. (OTC Pink:POTN) On [...]

ContraVir Pharmaceuticals Appoints Two New Hepatitis B Experts to Scientific Advisory Board

09/04/2018 - 12:00

EDISON, N.J., April 09, 2018 (GLOBE NEWSWIRE) -- ContraVir Pharmaceuticals, Inc. (NASDAQ: CTRV ), a biopharmaceutical company focused on the development and commercialization of targeted antiviral therapies, announced [...]

RavenQuest Common Shares Listed on OTC now DTC Eligible

09/04/2018 - 12:00

VANCOUVER, British Columbia, April 09, 2018 (GLOBE NEWSWIRE) -- RavenQuest BioMed Inc. (the “Company” or “RavenQuest”) – (CSE:RQB) (OTCQB:RVVQF) (Frankfurt: 1IT ) today announced that it has secured DTC Eligibility for [...]

Enzymatica AB: New ColdZyme study in elite athletes confirms preventive effect and reduced duration of illness

09/04/2018 - 11:31

News Lund April 9, 2018 New ColdZyme study in elite athletes confirms preventive effect and reduced duration of illness Enzymatica is now publishing the results of a second study 1 in which elite athletes used ColdZyme [...]

Transactions under Novozymes’ stock buyback program

09/04/2018 - 11:27

Please read the full announcement in the attached PDF Attachment 2018_12_Stock_Buybackprogram_EN